Biotech
$RMTI Dialysis Product Specialist Awaits Key SFP Clinical Trial Results
31 January 2012 – 12:16 am PST
Written by Mike Havrilla–Rockwell Medical (NASDAQ:RMTI) is focused on the development and commercialization of products and treatments for patients w/ late-stage kidney disease who require dialysis.
Continue reading...AMLN Video Gameplan for Monday January 30th
29 January 2012 – 12:16 am PST
Comments Off
$TSRX Reports Positive Results in First of Two Phase 3 Trials for Antibiotic Drug
27 January 2012 – 12:16 am PST
Comments Off
Written by Mike Havrilla–Trius Therapeutics (NASDAQ:TSRX) is focused on the development of antibiotics for life-threatening infections with a summary of the Company’s late-stage product candidate below.
Continue reading...Webinar – Thursday January 26th at 4:30pm EST
26 January 2012 – 12:16 am PST
Comments Off
$KOOL Cites Global Economic Crisis, Increased Competition for Weak Results
25 January 2012 – 12:16 am PST
Comments Off
Written by Mike Havrilla — ThermoGenesis (NASDAQ:KOOL) is a regenerative medicine company focused on the development and commercialization of products and devices for the collection, processing, and storage of adult stem cells derived from the bone marrow and cord blood sources, in addition to other blood-based components such as fibrin and platelets.
Continue reading...AMLN FDA Pre-Decision Options Trading Plan
24 January 2012 – 12:16 am PST
Comments Off
1 February 2012 – 12:16 am PST
View Comments